Cargando…
Should COVID-19 Vaccines Authorized for Emergency Use Be Considered “Essential” Medicines?
A critical debate in the race to develop, market, and distribute COVID-19 vaccines could define the future of this pandemic: How much evidence demonstrating a vaccine’s safety and efficacy should be required before it is considered “essential”? If a COVID-19 vaccine were to be designated an essentia...
Autores principales: | Smith, Maxwell J., Forman, Lisa, Parker, Michael, Perehudoff, Katrina, Rawson, Belinda, Sekalala, Sharifah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harvard University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233020/ https://www.ncbi.nlm.nih.gov/pubmed/34194208 |
Ejemplares similares
-
An intersectional human rights approach to prioritising access to COVID-19 vaccines
por: Sekalala, Sharifah, et al.
Publicado: (2021) -
The Role of Civil Society in Mobilizing Human Rights Struggles for Essential Medicines: A Critique from HIV/AIDS to COVID-19
por: Sekalala, Sharifah, et al.
Publicado: (2022) -
Health data justice: building new norms for health data governance
por: Shaw, James, et al.
Publicado: (2023) -
A human rights-based approach to the reimbursement of expensive medicines
por: Perehudoff, Katrina, et al.
Publicado: (2016) -
European governments should align medicines pricing practices with global transparency norms and legal principles
por: Perehudoff, Katrina
Publicado: (2022)